Clinical Trials Logo

Clinical Trial Summary

INtegrated Support Persons Into Recovery (INSPIRE) is a 4-year research project that tests whether integrating a patient's support person into a patient's treatment with Buprenorphine/Naloxone can improve outcomes. The study will examine whether a counseling program called CRAFT for a support person, such as a family member, spouse or friend, can improve patient outcomes.


Clinical Trial Description

Opioid use disorders (OUDs) have reached an all-time high and have devastating effects on the individual, family, and community. While medication treatment for OUD saves lives, rates of treatment drop out are very high. In addition, existing OUD treatments neglect the impact of untreated OUD on the family, and ignore the potential role family members and support persons (SPs) could have on encouraging long-term recovery. Incorporating the patient's support system may be an important way to improve treatment retention. The proposed study evaluates a counseling program for concerned family members, spouses, and friends called Community Reinforcement and Family Training (CRAFT), which is successful at engaging and retaining patients in substance use treatment. While promising, no studies have evaluated whether CRAFT can help patients remain on medication treatment for OUD, provided by community health clinics. If effective, this could save lives and help both patient and family member health outcomes. Patient and SP pairs will be recruited from 17 community health clinics throughout northern and southern California. Patients taking OUD medication treatment will be recruited and randomly assign half of the SPs to receive CRAFT; the other half would receive treatment-as-usual. Patients and SPs will be interviewed three and twelve months later to evaluate whether patients with CRAFT SPs stay in OUD treatment longer, and whether patient and SP health outcomes improve. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04239235
Study type Interventional
Source Stanford University
Contact Karen Osilla, PhD
Phone 3103930411
Email kosilla@stanford.edu
Status Recruiting
Phase N/A
Start date February 15, 2021
Completion date July 2024

See also
  Status Clinical Trial Phase
Completed NCT04336293 - sTMS for Substance Use-disordered Veterans N/A
Completed NCT01188421 - Medications Development for Drug Abuse Disorders Phase 1/Phase 2
Completed NCT00499746 - The Discriminative Effects of Tramadol in Humans Phase 1/Phase 2
Not yet recruiting NCT05611749 - Duloxetine Impact on Postoperative Pain Control and Outcomes Phase 2
Recruiting NCT04325659 - An Innovative Intervention for OUD Treatment Phase 2/Phase 3
Completed NCT03685162 - Observational Study to Evaluate Levomethadone Safety and Effectiveness in Subjects Under Opioid Maintenance Treatment
Not yet recruiting NCT03394911 - Healthy Adult Male Facial Skin Surface Lipid Pheromone p.o. to Treat Opioid Addiction Phase 3
Not yet recruiting NCT02282072 - PINS Stimulator System for Deep Brain Stimulation of the Nucleus Accumbens to Treat Severe Opioid Addiction Phase 0
Not yet recruiting NCT01008072 - Ultra-rapid Opiate Detoxification Using Deep Sedation and Prior Oral Buprenorphine Preparation. N/A
Completed NCT02696096 - Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence Phase 3
Recruiting NCT05299515 - Peer Activate: Trial of Peer-Delivered Behavioral Activation for Methadone Adherence N/A
Recruiting NCT04309565 - Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support N/A
Completed NCT01590251 - Yoga for Pain and Opioid Dependence Phase 1/Phase 2
Completed NCT01873989 - Testosterone Replacement for Male Opioid Agonist Maintained Patients Phase 1/Phase 2
Active, not recruiting NCT02866266 - ER/LA Opioid Surveillance for Emergency Department Visits and Hospitalizations for Overdose and Poisoning N/A
Enrolling by invitation NCT02871232 - Surveillance Monitoring of Opioid Abuse in Poison and Drug Treatment Centers N/A